Clinical Trial Update: A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder

View source ↗

Summary

This is a completed non-interventional study sponsored by AstraZeneca that evaluated treatment patterns of atypical antipsychotics in adults with Bipolar I or I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Bipolar Ii Disorder

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar Disorders | Status: COMPLETED